Benznidazole therapy for Chagas disease in asymptomatic Trypanosoma cruzi -seropositive former blood donors: evaluation of the efficacy of different treatment regimens

Antunes, André Pires; Ribeiro, Antônio Luiz Pinho; Sabino, Ester Cerdeira; Silveira, Marise Fagundes; Oliveira, Cláudia Di Lorenzo; Botelho, Ana Cristina de Carvalho.
Rev. Soc. Bras. Med. Trop ; 49(6): 713-720, Dec. 2016. tab, graf
Artículo en Inglés | LILACS | ID: biblio-829676

Documentos relacionados

  1. Ferrocene-based nitroheterocyclic sulfonylhydrazones: design, synthesis, characterization and trypanocidal properties.
  2. Trypanosoma cruzi: Does the intake of nanoencapsulated benznidazole control acute infections?
  3. Frequency Variation and Dose Modification of Benznidazole Administration for the Treatment of Trypanosoma cruzi Infection in Mice, Dogs, and Nonhuman Primates.
  4. Effect of B-NIPOx in Experimental <i>Trypanosoma cruzi</i> Infection in Mice.
  5. Drug Repurposing in Chagas Disease: Chloroquine Potentiates Benznidazole Activity against Trypanosoma cruzi <i>In Vitro</i> and <i>In Vivo</i>.
  6. Piplartine-Inspired 3,4,5-Trimethoxycinnamates: Trypanocidal, Mechanism of Action, and In Silico Evaluation.
  7. Benznidazole treatment leads to DNA damage in Trypanosoma cruzi and the persistence of rare widely dispersed non-replicative amastigotes in mice.
  8. Chagas disease: An underrecognized diagnosis.
  9. Monotherapy and combination chemotherapy for Chagas disease treatment: a systematic review of clinical efficacy and safety based on randomized controlled trials.
  10. Benznidazole, itraconazole, and their combination for the treatment of chronic experimental Chagas disease in dogs.